OKUR
OnKure Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.60
+3.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 63.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.61x
- Price / sales
- —
- Price / cash flow
- -2.20x
Enterprise value
- Enterprise value
- -$70.4M
- EV / sales
- —
- EV / EBITDA
- 1.22x
- EV / EBIT
- 1.13x
- Market cap
- $105.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026